Stockhead on MSN22m
Race gets ethics nod for Phase I trial in solid tumour patientsRace Oncology has been given ethics approval for a Phase I trial of RC220 bisantrene alone and in combination with ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback